Area of research
Cancer Research · Hepatology
Research interest
Research interests include Cancer, Lipids, and Metabolism, Hepatocellular Carcinoma Treatment and Prognosis, Cancer, Hypoxia, and Metabolism, and Inflammatory mediators and NSAID effects.
The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma
circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na+/K+-ATPase activity and hypoxia-inducible pathways
Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the <scp>YAP</scp>‐<scp>TEAD</scp> complex
Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway
Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways
Downregulating sCLU Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Gemcitabine by Activating the Intrinsic Apoptosis Pathway
Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma